Effects of 3 years of intravenous pamidronate treatment on bone markers and bone mineral density in a patient with osteoporosis-pseudoglioma syndrome (OPPG).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples